Qualcomm, United collaboration begins with employee wearable wellness program

Qualcomm Life and UnitedHealthcare are collaborating to develop and deliver connected health solutions to consumers across the U.S., focusing on programs and services that incorporate the latest generation of wearables, medical devices and diagnostic tests that leverage Qualcomm Life’s 2net Platform for medical-grade connectivity.

The first program under this new collaboration is UnitedHealthcare Motion, a health and wellness program powered by the 2net Connectivity Platform. UnitedHealthcare Motion is designed to guide plan participants to become healthier and more active, while helping them pay for the cost of everyday healthcare. Available on a select basis to companies with 101 to 300 employees with a fully insured health plan, the program provides employees and their covered spouses with custom-designed wearable devices that track the number of steps each user takes throughout the day, calculating the total number, frequency and intensity of the steps taken.

The data acquired from the wearable devices is then sent to the UnitedHealthcare Motion app. Employees with these wearable devices earn Health Reimbursement Account credits that can total up to $1,460 per year, based on their usage, helping to save on healthcare costs. Employers can also obtain premium savings based on the combined results of their program participants.

“We’re excited to collaborate with UnitedHealthcare in powering its connected care solutions, starting with the UnitedHealthcare Motion program,” said James Mault, MD, vice president and chief medical officer, Qualcomm Life. “UnitedHealthcare’s leadership in innovation and broad reach across the United States, combined with Qualcomm Life’s medical grade connectivity solutions, enable us to deliver personalized, connected care to millions of healthcare consumers nationwide.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.